ELI LILLY AND COMPANY
Identity (GLEIF Global LEI Index)
| Field | Value | Class |
|---|---|---|
| Legal name | ELI LILLY AND COMPANY | SF |
| LEI | FRDRIPF3EKNDJ2CQJL29 | SF |
| Swiss UID | 183025-143 | SF |
| Jurisdiction | US-IN | SF |
| Legal address | Lilly Corporation Centre, 46285, Indianapolis | SF |
| Headquarters | Lilly Corporation Centre, 46285, Indianapolis Indianapolis US-IN | SF |
| Entity status | ACTIVE | SF |
| Geneva connection | none | CM |
Listed securities (SIX Swiss Exchange issuer directory)
No securities linked (identity resolution pending — see Data Quality).
Market snapshot
No linked security
No price history in this build — no credential-free market-data source was reachable from the build environment. The Yahoo/Stooq adapters are implemented and will populate on first live run; keyed providers (Twelve Data, Alpha Vantage) activate via .env.
Analyst price targets
No verified analyst price target recorded for this security yet. Configured target providers (FMP consensus slice, Twelve Data US phase, Yahoo quoteSummary) fill the universe progressively within their daily call budgets; a symbol the providers do not cover keeps this honest state. Values are never estimated.
3 further data fields this platform tracks — no connected source covers this issuer yet. Shown to demonstrate capacity; each populates automatically when a source does, and nothing is estimated in the meantime. Show what is tracked ›
Financials (latest reported period)
Most recent reported income-statement figures (company disclosure redistributed by the named source); absent figures stay absent — never estimated.
No reported financial statements ingested for this company yet. Sources reach issuers progressively within their daily budgets: the keyed FMP weekly rotation (Mon income / Fri balance / Sat cash-flow families; US-listed free tier) plus — since 2026-07-07 — official filing-based paths: SEC XBRL company facts (US and 20-F/40-F cross-listed issuers with a resolved CIK) and filings.xbrl.org ESEF facts (EU/EEA issuers by LEI, where the national OAM shares). Figures are company disclosures — never estimated.
Recent company events
News, insider transactions, congressional trading disclosures and analyst-estimate snapshots from connected sources, each with provenance. Analyst estimates are forecasts — never price targets.
No company events ingested yet — the FMP rotation families (news, insider transactions, congressional disclosures, analyst estimates) populate this once a key is configured. Nothing is invented in the meantime.
Segment & geographic revenue (company disclosures)
Figures parsed from filings and redistributed by the named provider; values are shown as reported and shares are Calculated Metrics with the formula in the column header.
No disclosed segment or geographic revenue ingested for this company yet. The Business Quant pipeline (SEC-parsed company disclosures) reaches US-listed issuers progressively within its daily budget; issuers that do not disclose segment detail keep this honest state.
How the company makes money
Business description and sector are sourced facts (Yahoo assetProfile / Wikidata / Wikipedia — source named per value); the registry-disclosed purpose follows. Disclosed segment/geographic revenue appears in the card above when the issuer reports it; official EDGAR-XBRL and ESEF facts feed the financials card since 2026-07-07. Nothing is estimated in the meantime.
Registry-disclosed purpose: Access currently requires credentials — the Swiss registry (Zefix) API returned HTTP 401 anonymously (verified 2026-07-02); registered-purpose text will populate once free Zefix credentials are configured in .env.
Corporate registry (OpenCorporates)
Official company-registry data aggregated by OpenCorporates; each value carries the registry's own snapshot date. Officers appear only where the registry publishes them (Swiss registries do not). The presence sweep lists same-name registrations across jurisdictions as labelled inference — never asserted subsidiaries.
Status: ACTIVE · Legal form: R0BI · Registered address: Lilly Corporation Centre, 46285, Indianapolis · OC jurisdiction: US-IN · registry record ↗ · registry snapshot as of 2025-01-31
Officers (31 on register):
- David Ricks — other (since 2025-01-23)
- Gabrielle Sulzberger — other (since 2025-01-23)
- J. Erik Fyrwald — other (since 2025-01-23)
- Jamere Jackson — other (since 2025-01-23)
- Jon Moeller — other (since 2025-01-23)
- Juan Luciano — other (since 2025-01-23)
Registry presence sweep (77 candidate entities, Evidence-Based Inference — match basis recorded per row): us_in (8) · gb (3) · fr (2) · in (2) · nz (2) · pr (2) · us_fl (2) · us_la (2) · us_md (2) · us_mo (2)
Regulators of highest concern
Ranked by maximum applicability of evidence-backed matches; when none exist yet, the jurisdictional supervision context derived from listing venue/domicile is shown instead — labelled, never asserted as a match.
Jurisdictional supervision context
| Competent authority | Derived from | Class | Note |
|---|---|---|---|
| OFAC — Office of Foreign Assets Control (US sanctions) | disclosed domicile US | SF | derived from listing venue/domicile |
No evidence-backed matches yet — concern ranking derives only from evidence-backed matches; the authorities above are jurisdictional context from the recorded listing venue/domicile, not matches.
Regulatory exposure — matches with evidence
The price-impact column is a LABELLED INFERENCE (EBI): reasoning about whether and why the exposure could bear on the share price, derived from the regulation's type, region and topic and the match layer/direction. It is not an asserted fact and states no magnitude; the Applicability/Confidence/Exposure figures and the linked evidence remain the sourced basis.
No matches for this company under the current rule set.
Recent filings — potential impact inputs
A filing flags potential impact only via evidence-backed matching between its disclosed content and tracked measures.
No filings ingested for this company yet, and no listing venue/CIK is recorded from which the authoritative filing channel could be derived. ESEF/OAM filing content is a phased expansion tracked in the plan; filing-impact assessment activates only when real filings and matches coexist — it is never guessed.
MERIDIAN